Product Name

Synthetic route

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 8h;95.77%
With potassium carbonate In 1-methyl-pyrrolidin-2-one at 75℃; for 6h;93%
With sodium carbonate In N,N-dimethyl acetamide at 100℃; for 6h; Temperature; Large scale;89.4%
N-(2-acetylphenyl)-2-[8-bromo-7-(but-2-yn-1-yl)-3-methyl -2,6-dioxo-2,3,6,7-tetrahydro- 1H-purin-1-yl]acetamide

N-(2-acetylphenyl)-2-[8-bromo-7-(but-2-yn-1-yl)-3-methyl -2,6-dioxo-2,3,6,7-tetrahydro- 1H-purin-1-yl]acetamide

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With ammonium acetate; acetic acid at 95 - 100℃; Inert atmosphere;95%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-p-toluenesulfonylmethyl-4-methylquinazoline

2-p-toluenesulfonylmethyl-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 6h;93%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

4-chloromethyl-2-methylquinazoline

4-chloromethyl-2-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In 1-methyl-pyrrolidin-2-one at 75℃; for 3h; Temperature; Large scale;90%
C16H13BrN6O2

C16H13BrN6O2

1-Bromo-2-butyne
3355-28-0

1-Bromo-2-butyne

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 50℃; for 3h;86.3%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(1-bromomethyl)-4-methylquinazoline

2-(1-bromomethyl)-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 7h;82%
With sodium carbonate In 1-methyl-pyrrolidin-2-one at 100 - 120℃;72%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-halogenomethyl-4-methyl-quinazoline

2-halogenomethyl-4-methyl-quinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 6h;
3-methyl-8-bromoxanthine
93703-24-3

3-methyl-8-bromoxanthine

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 20 - 30 °C
1.2: 25 - 30 °C
2.1: tetrabutylammomium bromide; potassium carbonate / dimethyl sulfoxide / 75 - 80 °C
View Scheme
Multi-step reaction with 2 steps
1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 20 °C
2: sodium carbonate / N,N-dimethyl-formamide / 12 h / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 4 h / 80 °C
2: potassium carbonate / N,N-dimethyl-formamide / 6 h / 65 °C
View Scheme
3-methylxanthine
1076-22-8

3-methylxanthine

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium acetate / acetic acid / 25 - 30 °C
1.2: 10 - 65 °C
2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 20 - 30 °C
2.2: 25 - 30 °C
3.1: tetrabutylammomium bromide; potassium carbonate / dimethyl sulfoxide / 75 - 80 °C
View Scheme
Multi-step reaction with 3 steps
1: sodium acetate; acetic acid; bromine / 2 h / 65 °C
2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 4 h / 80 °C
3: potassium carbonate / N,N-dimethyl-formamide / 6 h / 65 °C
View Scheme
Multi-step reaction with 3 steps
1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
3: potassium carbonate / N,N-dimethyl acetamide / 75 - 95 °C
View Scheme
Multi-step reaction with 3 steps
1.1: acetic acid; sodium acetate / 25 - 30 °C
1.2: 10 - 65 °C
2.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
3.1: potassium carbonate; tetrabutylammomium bromide / dimethyl sulfoxide / 20 - 80 °C
View Scheme
Multi-step reaction with 3 steps
1: sodium acetate; acetic acid; bromine / 3 h / 65 °C
2: triethylamine / N,N-dimethyl-formamide / 10 h / 20 °C
3: potassium carbonate / N,N-dimethyl-formamide / 8 h / 90 °C
View Scheme
2-aminoacetophenone
551-93-9

2-aminoacetophenone

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogenchloride / 1,4-dioxane / 10 °C / Cooling
1.2: 1 h / -10 °C
2.1: potassium carbonate / N,N-dimethyl-formamide / 6 h / 65 °C
View Scheme
Multi-step reaction with 2 steps
1: hydrogenchloride / 1,4-dioxane / 2 h / 6 °C
2: sodium carbonate / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C
View Scheme
Multi-step reaction with 2 steps
1: copper(l) chloride; oxygen; potassium carbonate / tetrahydrofuran / 12 h / Reflux
2: potassium carbonate / N,N-dimethyl-formamide / 6 h / 80 °C
View Scheme
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-(2-bromoethyl)-4-methylquinazoline

2-(2-bromoethyl)-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl acetamide at 20℃; for 8h;
N-(2-acetylphenyl)-2-chloroacetamide
6140-11-0

N-(2-acetylphenyl)-2-chloroacetamide

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium iodide; potassium carbonate / dimethyl sulfoxide / 50 - 55 °C / Inert atmosphere
2: ammonium acetate; acetic acid / 95 - 100 °C / Inert atmosphere
View Scheme
8-bromo-3-methyl-7-(thietan-3-yl)-3,7-dihydro-1H-pyrine-2,6-dione
1005482-51-8

8-bromo-3-methyl-7-(thietan-3-yl)-3,7-dihydro-1H-pyrine-2,6-dione

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: potassium hydroxide / N,N-dimethyl-formamide; water / 0.5 h
1.2: 6 h / 20 °C
2.1: acetic acid; dihydrogen peroxide / 0.5 h / Reflux
3.1: sodium ethanolate; ethanol / 1 h / Reflux; Inert atmosphere
4.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 3 h / 50 °C
View Scheme
C19H17BrN6O2S

C19H17BrN6O2S

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid; dihydrogen peroxide / 0.5 h / Reflux
2: sodium ethanolate; ethanol / 1 h / Reflux; Inert atmosphere
3: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 3 h / 50 °C
View Scheme
C19H17BrN6O4S

C19H17BrN6O4S

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium ethanolate; ethanol / 1 h / Reflux; Inert atmosphere
2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 3 h / 50 °C
View Scheme
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

A

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

B

C40H34Br2N12O4

C40H34Br2N12O4

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl acetamide at 75 - 85℃;A n/a
B 2 g
6-amino-1-methyluracil
2434-53-9

6-amino-1-methyluracil

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: acetic acid; sodium nitrite / water / 1 h / 50 °C
2.1: ammonium hydroxide; sodium dithionite / 1 h / 35 - 60 °C
3.1: water / 3 h / 105 °C
3.2: 1 h / 105 °C
4.1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
5.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
6.1: potassium carbonate / N,N-dimethyl acetamide / 75 - 95 °C
View Scheme
Multi-step reaction with 6 steps
1.1: acetic acid; sodium nitrite / water / 1 h / 50 °C
2.1: sodium dithionite; ammonia / 1 h / 50 °C
3.1: water / 3 h / Reflux; Inert atmosphere
4.1: acetic acid; sodium acetate / 25 - 30 °C
4.2: 10 - 65 °C
5.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
6.1: potassium carbonate; tetrabutylammomium bromide / dimethyl sulfoxide / 20 - 80 °C
View Scheme
6-amino-1-methyl-5-nitrosouracil
6972-78-7

6-amino-1-methyl-5-nitrosouracil

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: ammonium hydroxide; sodium dithionite / 1 h / 35 - 60 °C
2.1: water / 3 h / 105 °C
2.2: 1 h / 105 °C
3.1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
4.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
5.1: potassium carbonate / N,N-dimethyl acetamide / 75 - 95 °C
View Scheme
Multi-step reaction with 5 steps
1.1: sodium dithionite; ammonia / 1 h / 50 °C
2.1: water / 3 h / Reflux; Inert atmosphere
3.1: acetic acid; sodium acetate / 25 - 30 °C
3.2: 10 - 65 °C
4.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
5.1: potassium carbonate; tetrabutylammomium bromide / dimethyl sulfoxide / 20 - 80 °C
View Scheme
5,6-diamino-1-methyluracil
6972-82-3

5,6-diamino-1-methyluracil

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: water / 3 h / 105 °C
1.2: 1 h / 105 °C
2.1: acetic acid; sodium acetate; bromine / 2 h / 65 °C
3.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 20 °C
4.1: potassium carbonate / N,N-dimethyl acetamide / 75 - 95 °C
View Scheme
Multi-step reaction with 4 steps
1.1: water / 3 h / Reflux; Inert atmosphere
2.1: acetic acid; sodium acetate / 25 - 30 °C
2.2: 10 - 65 °C
3.1: N-ethyl-N,N-diisopropylamine / acetone / Reflux
4.1: potassium carbonate; tetrabutylammomium bromide / dimethyl sulfoxide / 20 - 80 °C
View Scheme
4-(N-methylamino)-1H-imidazole-5-carboxamide
90801-87-9

4-(N-methylamino)-1H-imidazole-5-carboxamide

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: perchloric acid adsorbed on silica gel; formic acid / ethanol / 0.33 h / 20 °C
2: sodium acetate; acetic acid; bromine / 3 h / 65 °C
3: triethylamine / N,N-dimethyl-formamide / 10 h / 20 °C
4: potassium carbonate / N,N-dimethyl-formamide / 8 h / 90 °C
View Scheme
3-(R)-aminopiperidine dihydrochloride

3-(R)-aminopiperidine dihydrochloride

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Linagliptin

Linagliptin

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 60 - 70℃; for 7h; Large scale;96.7%
With triethyl borane; sodium carbonate; 4-methyl-2-pentanone at 95 - 100℃; for 10h; Concentration;93.8%
With potassium carbonate; potassium iodide In acetic acid butyl ester; toluene at 40 - 125℃; pH=11 - 12; Solvent;47%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

C13H26N2*C4H6O6

C13H26N2*C4H6O6

C31H42N8O2Si2

C31H42N8O2Si2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 80℃;96%
(R)-piperidin-3-ylcarbamic acid tert-butyl ester
309956-78-3

(R)-piperidin-3-ylcarbamic acid tert-butyl ester

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide; acetonitrile at 84 - 86℃; for 20h;95.3%
With potassium carbonate In dimethyl sulfoxide; acetonitrile at 20 - 86℃; for 20h; Temperature;95.3%
With potassium carbonate; potassium iodide In dimethyl sulfoxide at 80 - 85℃; Reagent/catalyst;91%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

C20H20N2O2*C4H6O6

C20H20N2O2*C4H6O6

C40H36N8O4

C40H36N8O4

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 140℃; for 3h;95%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

C7H10N2O2S2*C4H6O6

C7H10N2O2S2*C4H6O6

C27H26N8O4S2

C27H26N8O4S2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 80℃; for 3h;94.3%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

ethanolamine
141-43-5

ethanolamine

7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
In toluene for 2h; Reflux;94.2%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

C13H10Cl4N2O2*C4H6O6

C13H10Cl4N2O2*C4H6O6

C33H26Cl4N8O4

C33H26Cl4N8O4

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 80 - 140℃; for 3h;94.1%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-2-(piperidin-3-yl)isoindoline-1,3-dione D-(-)-tartaric acid salt
886588-62-1

(R)-2-(piperidin-3-yl)isoindoline-1,3-dione D-(-)-tartaric acid salt

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 140℃; for 2h;94%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

C21H20N2O2*C4H6O6

C21H20N2O2*C4H6O6

C41H36N8O4

C41H36N8O4

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 140℃;92%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

C11H18N2*C4H6O6

C11H18N2*C4H6O6

C31H34N8O2

C31H34N8O2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 100℃;92%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-3-(benzylideneamino)piperidine

(R)-3-(benzylideneamino)piperidine

(R)-8-(3-(benzylideneamino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-(benzylideneamino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium carbonate In toluene at 100℃; Temperature;91.2%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1-methyl-pyrrolidin-2-one at 140℃; for 2h;90%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-3-piperidinyl phthalimide hydrochloride

(R)-3-piperidinyl phthalimide hydrochloride

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
Stage #1: 2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione; 3-(R)-piperidinyl phthalimide hydrochloride With potassium carbonate In Isopropyl acetate for 0.5h;
Stage #2: With benzyltrimethylammonium chloride In Isopropyl acetate for 16h; Solvent; Reflux;
88.7%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

dimethyl amine
124-40-3

dimethyl amine

7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione

7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl-formamide at 25 - 55℃; for 24h; Inert atmosphere;71.66%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(3R)-3-aminopyrrolidine dihydrochloride
103831-11-4, 116183-81-4, 116183-83-6, 122458-34-8

(3R)-3-aminopyrrolidine dihydrochloride

(R)-8-(3-aminopyrrolidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-1H-purine-2,6(3H,7H)-dione

(R)-8-(3-aminopyrrolidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 75℃; for 6h;70%
piperidine
110-89-4

piperidine

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-1-yl)-1H-purine-2,6(3H,7H)-dione

7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-1-yl)-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 6h;67%
piperazine
110-85-0

piperazine

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperazin-1-yl)-1H-purine-2,6(3H,7H)-dione

7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperazin-1-yl)-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
In DMF (N,N-dimethyl-formamide) at 200℃; for 0.0833333h; Microwave irradiation;66%
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 6h;58%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(S)-3-aminopyrrolidine dihydrochloride
103831-11-4, 116183-81-4, 116183-83-6, 122458-34-8

(S)-3-aminopyrrolidine dihydrochloride

(S)-8-(3-aminopyrrolidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-1H-purine-2,6(3H,7H)-dione

(S)-8-(3-aminopyrrolidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 75℃; for 6h;65%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

tert-butyl (S)-piperidin-3-yl-carbamate
216854-23-8

tert-butyl (S)-piperidin-3-yl-carbamate

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(S)-tert-butoxycarbonylaminopiperidin-1-yl)xanthine
668273-74-3

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(S)-tert-butoxycarbonylaminopiperidin-1-yl)xanthine

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran for 16h; Reflux;65%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-1-cyclohexyl-N-(piperidin-3-yl)methanimine

(R)-1-cyclohexyl-N-(piperidin-3-yl)methanimine

(R)-7-(but-2-yn-1-yl)-8-(3-((cyclohexylmethylen)amino)piperidin-1-yl)-3-methyl-1-((4-methyilquinazolin-2-yl)methyl)-3,7-dihydro-1H-purin-2,6-dione

(R)-7-(but-2-yn-1-yl)-8-(3-((cyclohexylmethylen)amino)piperidin-1-yl)-3-methyl-1-((4-methyilquinazolin-2-yl)methyl)-3,7-dihydro-1H-purin-2,6-dione

Conditions
ConditionsYield
With potassium phosphate In 1-methyl-pyrrolidin-2-one; toluene at 103℃;64.2%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(S)-octahydropyrrolo[1,2-a]pyrazine
93643-24-4

(S)-octahydropyrrolo[1,2-a]pyrazine

(S)-7-(but-2-ynyl)-8-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

(S)-7-(but-2-ynyl)-8-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 75℃; for 6h;60%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

3-phenyl-N-((R)-piperidin-3-yl)prop-2-en-1-imine

3-phenyl-N-((R)-piperidin-3-yl)prop-2-en-1-imine

7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-((R)-3-(((1E,2E)-3-phenylallylidene)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione

7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-((R)-3-(((1E,2E)-3-phenylallylidene)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium phosphate In 1-methyl-pyrrolidin-2-one; toluene at 103℃;56.5%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-1-(4-methylphenyl)-N-(piperidin-3-yl)methanimine

(R)-1-(4-methylphenyl)-N-(piperidin-3-yl)methanimine

(R)-8-(3-(4-methylbenzylideneamino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-(4-methylbenzylideneamino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium phosphate In 1-methyl-pyrrolidin-2-one; toluene at 103℃;54.7%
2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

(R)-1-(4-nitrophenyl)-N-(piperidin-3-yl)methanimine

(R)-1-(4-nitrophenyl)-N-(piperidin-3-yl)methanimine

(R)-8-(3-(4-nitrobenzylideneamino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-(4-nitrobenzylideneamino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

Conditions
ConditionsYield
With potassium phosphate In 1-methyl-pyrrolidin-2-one; toluene at 103℃;54.7%

8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione Specification

The 1H-Purine-2,6-dione,8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-, with the CAS registry number 853029-57-9, is also known as 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine. This chemical's molecular formula is C20H17BrN6O2 and molecular weight is 453.00. What's more, its systematic name is called 8-Bromo-7-(2-butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-3,7-dihydro-1H-purine-2,6-dione.

Physical properties about 1H-Purine-2,6-dione,8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- are: (1)ACD/LogP: 3.96±1.01; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.96 ; (4)ACD/LogD (pH 7.4): 3.96; (5)ACD/BCF (pH 5.5): 598.76; (6)ACD/BCF (pH 7.4): 599.37; (7)ACD/KOC (pH 5.5): 3384.03; (8)ACD/KOC (pH 7.4): 3387.48; (9)#H bond acceptors: 8; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 3; (12)Polar Surface Area: 84.22 Å2; (13)Index of Refraction: 1.713; (14)Molar Refractivity: 114.3±0.5 cm3; (15)Molar Volume: 291.3±7.0 cm3; (16)Polarizability: 45.3±0.5×10-24cm3; (17)Surface Tension: 57.2±7.0 dyne/cm; (18)Density: 1.6±0.1 g/cm3; (19)Flash Point: 291.8±32.9 °C; (20)Enthalpy of Vaporization: 84.1±3.0 kJ/mol; (21)Boiling Point: 558.8±60.0 °C at 760 mmHg; (22)Vapour Pressure: 0.0±1.5 mmHg at 25 °C.

You can still convert the following datas into molecular structure:
(1) SMILES: CC#CCn1c2c(nc1Br)n(c(=O)n(c2=O)Cc3nc(c4ccccc4n3)C)C
(2) InChI: InChI=1S/C20H17BrN6O2/c1-4-5-10-26-16-17(24-19(26)21)25(3)20(29)27(18(16)28)11-15-22-12(2)13-8-6-7-9-14(13)23-15/h6-9H,10-11H2,1-3H3
(3) InChIKey: RCZJXCXNYGHNSR-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View